Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | Q4 2025 ▲▼ | Q1 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| KLA Corporation(KLAC) | 21,883 | 19,883 | -2,000 | $26.59M | $29.28M | 16.67% | +$2.69M |
| Bristol-Myers Squibb Company(BMY) | 302,842 | 306,268 | +3,426 | $16.34M | $18.58M | 10.57% | +$2.24M |
| Compass Therapeutics, Inc.(CMPX) | 1,592,938 | 1,465,867 | -127,071 | $8.55M | $7.75M | 4.41% | -$799.6K |
| Lam Research Corporation(LRCX) | 40,329 | 36,000 | -4,329 | $6.90M | $7.69M | 4.38% | +$788.2K |
| Stoke Therapeutics, Inc.(STOK) | 260,000 | 210,000 | -50,000 | $8.25M | $6.84M | 3.89% | -$1.41M |
| Ovintiv Inc.(OVV) | 107,500 | 107,500 | 0 | $4.21M | $6.38M | 3.63% | +$2.17M |
| Intellia Therapeutics, Inc.(NTLA) | 315,400 | 445,400 | +130,000 | $2.84M | $5.71M | 3.25% | +$2.87M |
| Structure Therapeutics IncADR | 90,000 | 100,000 | +10,000 | $6.26M | $4.82M | 2.74% | -$1.44M |
| Solid Biosciences Inc | 705,955 | 625,980 | -79,975 | $3.98M | $4.51M | 2.57% | +$525.5K |
| Prothena Corp PlcSHS SHS | 441,019 | 449,019 | +8,000 | $4.21M | $4.36M | 2.48% | +$152.7K |
| Biodesix, Inc.(BDSX) | 286,804 | 286,804 | 0 | $1.95M | $4.16M | 2.37% | +$2.21M |
| Acadia Pharmaceuticals Inc | 171,000 | 171,000 | 0 | $4.57M | $3.81M | 2.17% | -$761.0K |
| Protagonist Therapeutics Inc | 55,000 | 35,000 | -20,000 | $4.80M | $3.69M | 2.10% | -$1.11M |
| Neurocrine Biosciences, Inc.(NBIX) | 27,190 | 27,190 | 0 | $3.86M | $3.58M | 2.04% | -$274.3K |
| Olema Pharmaceuticals, Inc.(OLMA) | 269,000 | 219,000 | -50,000 | $6.72M | $3.27M | 1.86% | -$3.46M |
| Relmada Therapeutics, Inc.(RLMD) | 0 | 409,387 | +409,387 | $0 | $2.85M | 1.62% | +$2.85M |
| Ocular Therapeutix, Inc.(OCUL) | 0 | 320,000 | +320,000 | $0 | $2.71M | 1.54% | +$2.71M |
| United Therapeutics Corporation(UTHR) | 3,000 | 4,500 | +1,500 | $1.46M | $2.67M | 1.52% | +$1.21M |
| Nektar Therapeutics(NKTR) | 31,000 | 31,000 | 0 | $1.31M | $2.23M | 1.27% | +$919.8K |
| Celldex Therapeutics, Inc.(CLDX) | 0 | 70,095 | +70,095 | $0 | $2.22M | 1.27% | +$2.22M |
| NovoCure Limited(NVCR) | 152,100 | 202,330 | +50,230 | $1.97M | $2.21M | 1.26% | +$238.7K |
| EQT Corporation(EQT) | 34,619 | 34,619 | 0 | $1.86M | $2.20M | 1.25% | +$347.6K |
| Phathom Pharmaceuticals, Inc.(PHAT) | 195,000 | 195,000 | 0 | $3.24M | $2.17M | 1.23% | -$1.07M |
| Bicycle Therapeutics PlcADS | 462,700 | 463,599 | +899 | $3.28M | $2.15M | 1.22% | -$1.12M |
| COMPASS Pathways plcADS(CMPS) | 0 | 375,000 | +375,000 | $0 | $2.07M | 1.18% | +$2.07M |
| Pacific Biosciences of California, Inc.(PACB) | 500,000 | 1,500,000 | +1,000,000 | $935.0K | $1.98M | 1.13% | +$1.04M |
| Cytokinetics, Incorporated(CYTK) | 30,000 | 30,000 | 0 | $1.91M | $1.98M | 1.13% | +$71.1K |
| Corcept Therapeutics Incorporated(CORT) | 67,200 | 47,200 | -20,000 | $2.34M | $1.90M | 1.08% | -$435.9K |
| Vera Therapeutics, Inc.CL A(VERA) | 44,000 | 44,000 | 0 | $2.23M | $1.77M | 1.01% | -$458.0K |
| Alkermes plcSHS(ALKS) | 50,000 | 50,000 | 0 | $1.40M | $1.77M | 1.01% | +$369.0K |
| Engene Holdings Inc COM | 0 | 250,000 | +250,000 | $0 | $1.70M | 0.97% | +$1.70M |
| uniQure N.V.SHS(QURE) | 30,789 | 100,697 | +69,908 | $736.8K | $1.65M | 0.94% | +$909.6K |
| Zenas BioPharma, Inc.(ZBIO) | 0 | 70,000 | +70,000 | $0 | $1.37M | 0.78% | +$1.37M |
| Quidelortho Corp | 72,548 | 82,548 | +10,000 | $2.07M | $1.36M | 0.77% | -$715.7K |
| Foghorn Therapeutics Inc.(FHTX) | 281,730 | 281,730 | 0 | $1.52M | $1.35M | 0.77% | -$174.7K |
| Ultragenyx Pharmaceutical Inc.(RARE) | 62,000 | 62,000 | 0 | $1.43M | $1.30M | 0.74% | -$127.1K |
| Xenon Pharmaceuticals Inc.(XENE) | 21,000 | 21,000 | 0 | $941.2K | $1.22M | 0.70% | +$279.9K |
| Kalvista Pharmaceuticals Inc | 57,000 | 57,000 | 0 | $920.5K | $1.15M | 0.65% | +$226.9K |
| Immunome, Inc.(IMNM) | 130,000 | 50,000 | -80,000 | $2.79M | $1.09M | 0.62% | -$1.70M |
| Freeport-McMoRan Inc.CL B(FCX) | 18,046 | 18,040 | -6 | $916.6K | $1.06M | 0.60% | +$143.8K |
| Axsome Therapeutics, Inc.(AXSM) | 6,061 | 6,000 | -61 | $1.11M | $1.01M | 0.58% | -$92.9K |
| Biogen Inc.(BIIB) | 0 | 5,000 | +5,000 | $0 | $916.6K | 0.52% | +$916.6K |
| Lipocine Inc.(LPCN) | 0 | 111,786 | +111,786 | $0 | $893.2K | 0.51% | +$893.2K |
| Travere Therapeutics, Inc.(TVTX) | 43,000 | 29,200 | -13,800 | $1.64M | $867.5K | 0.49% | -$775.5K |
| Harrow, Inc.(HROW) | 34,000 | 24,000 | -10,000 | $1.67M | $846.2K | 0.48% | -$819.8K |
| Pharvaris N V COM | 29,847 | 29,847 | 0 | $828.3K | $843.2K | 0.48% | +$14.9K |
| Verastem, Inc.(VSTM) | 150,000 | 150,000 | 0 | $1.16M | $795.0K | 0.45% | -$363.0K |
| Apogee Therapeutics Inc | 16,000 | 9,000 | -7,000 | $1.21M | $757.5K | 0.43% | -$450.1K |
| Halozyme Therapeutics, Inc.(HALO) | 10,100 | 10,100 | 0 | $679.7K | $652.8K | 0.37% | -$27.0K |
| BridgeBio Pharma, Inc.(BBIO) | 8,688 | 8,688 | 0 | $664.5K | $645.2K | 0.37% | -$19.4K |
| Apellis Pharmaceuticals Inc COM | 14,000 | 14,000 | 0 | $351.7K | $563.2K | 0.32% | +$211.5K |
| IDEAYA Biosciences, Inc.(IDYA) | 0 | 16,860 | +16,860 | $0 | $561.8K | 0.32% | +$561.8K |
| Arcus Biosciences, Inc.(RCUS) | 0 | 25,889 | +25,889 | $0 | $559.2K | 0.32% | +$559.2K |
| REGENXBIO Inc.(RGNX) | 0 | 66,270 | +66,270 | $0 | $555.3K | 0.32% | +$555.3K |
| Karyopharm Therapeutics Inc.(KPTI) | 0 | 83,952 | +83,952 | $0 | $467.6K | 0.27% | +$467.6K |
| Rocket Pharmaceuticals, Inc.(RCKT) | 0 | 127,025 | +127,025 | $0 | $454.8K | 0.26% | +$454.8K |
| Viridian Therapeutics, Inc.(VRDN) | 0 | 20,100 | +20,100 | $0 | $393.2K | 0.22% | +$393.2K |
| Outset Medical, Inc.(OM) | 98,913 | 98,882 | -31 | $367.0K | $379.7K | 0.22% | +$12.7K |
| Pulmonx Corporation(LUNG) | 250,573 | 250,221 | -352 | $553.8K | $322.8K | 0.18% | -$231.0K |
| Castle Biosciences, Inc.(CSTL) | 80,600 | 12,900 | -67,700 | $3.14M | $316.7K | 0.18% | -$2.82M |
| Trinity Capital Inc.(TRIN) | 20,000 | 20,000 | 0 | $293.0K | $294.2K | 0.17% | +$1.2K |
| Candel Therapeutics, Inc.(CADL) | 60,000 | 60,000 | 0 | $339.0K | $294.0K | 0.17% | -$45.0K |
| Voyager Therapeutics, Inc.(VYGR) | 74,918 | 74,918 | 0 | $294.4K | $289.2K | 0.16% | -$5.2K |
| Cullinan Therapeutics, Inc.(CGEM) | 20,000 | 20,000 | 0 | $207.0K | $284.2K | 0.16% | +$77.2K |
| Kayne Anderson BDC, Inc.(KBDC) | 20,000 | 20,000 | 0 | $286.4K | $274.4K | 0.16% | -$12.0K |
| Grace Therapeutics, Inc.(GRCE) | 0 | 50,000 | +50,000 | $0 | $231.5K | 0.13% | +$231.5K |
| Elutia Inc.(ELUT) | 263,018 | 165,094 | -97,924 | $182.2K | $173.3K | 0.10% | -$8.8K |
| Kyntra Bio, Inc.(KYNB) | 0 | 22,566 | +22,566 | $0 | $153.0K | 0.09% | +$153.0K |
| Quoin Pharmaceuticals, Ltd.ADS(QNRX) | 0 | 20,000 | +20,000 | $0 | $132.0K | 0.08% | +$132.0K |
| Phreesia, Inc.(PHR) | 110,700 | 14,300 | -96,400 | $1.87M | $119.8K | 0.07% | -$1.75M |
| Zentalis Pharmaceuticals, Inc.(ZNTL) | 17,000 | 17,503 | +503 | $22.9K | $41.0K | 0.02% | +$18.0K |
| DocGo Inc.(DCGO) | 49,908 | 39,573 | -10,335 | $43.8K | $24.9K | 0.01% | -$18.9K |
| Gossamer Bio, Inc.(GOSS) | 138,176 | 18,176 | -120,000 | $428.3K | $6.0K | 0.00% | -$422.4K |
| 10x Genomics, Inc.(TXG) | 59,000 | 0 | -59,000 | $962.3K | $0 | — | -$962.3K |
| Alumis Inc | 10,000 | 0 | -10,000 | $97.6K | $0 | — | -$97.6K |
| Amicus Therapeutics Inc COM | 253,000 | 0 | -253,000 | $3.60M | $0 | — | -$3.60M |
| Alphatec Holdings, Inc.(ATEC) | 18,058 | 0 | -18,058 | $379.9K | $0 | — | -$379.9K |
| Biohaven Ltd | 59,365 | 0 | -59,365 | $670.2K | $0 | — | -$670.2K |
| Illumina, Inc.(ILMN) | 6,000 | 0 | -6,000 | $787.0K | $0 | — | -$787.0K |
| Inhibrx Biosciences, Inc.(INBX) | 3,698 | 0 | -3,698 | $292.1K | $0 | — | -$292.1K |
| Liquidia Corporation(LQDA) | 10,000 | 0 | -10,000 | $344.9K | $0 | — | -$344.9K |
| Masimo Corp | 8,280 | 0 | -8,280 | $1.08M | $0 | — | -$1.08M |
| Rapt Therapeutics Inc | 15,000 | 0 | -15,000 | $508.1K | $0 | — | -$508.1K |
| Treace Medical Concepts, Inc.(TMCI) | 226,947 | 0 | -226,947 | $556.0K | $0 | — | -$556.0K |
| Ventyx Biosciences Inc | 100,827 | 0 | -100,827 | $910.5K | $0 | — | -$910.5K |